KLOW (BPC-157 / TB500 / GHK-Cu / KPV)

$164.99

Research-Use Only Disclaimer

The BPC-157 / TB-500 / GHK-Cu Blend is provided strictly for laboratory research purposes. It is not approved for human or animal administration and must not be used for therapeutic, diagnostic, or clinical applications. Handling is restricted to trained and authorized research professionals.

$164.99

Description

Multi-Pathway Regenerative Research Model for Tissue Repair, Angiogenesis & Cellular Remodeling

Overview

The BPC-157 / TB-500 / GHK-Cu blend combines three well-studied peptides—each with distinct yet complementary biological roles—into a comprehensive model for tissue repair, cellular regeneration, and structural remodeling in preclinical research.

  • BPC-157 is known for its potential to support gastrointestinal integrity, angiogenesis, and soft-tissue repair.
  • TB-500 (Thymosin Beta-4 fragment) is recognized for its involvement in cell migration, tissue recovery, and modulation of inflammation.
  • GHK-Cu, a copper peptide complex, is widely studied for promoting collagen production, wound healing, and anti-inflammatory activity.

Together, these peptides form a multi-mechanistic research tool for studying integrative regenerative pathways.

Preclinical Research Background

BPC-157

Research suggests that BPC-157 may:

  • Promote angiogenesis and blood-flow restoration
  • Support tendon, ligament, and muscle regeneration
  • Modulate inflammatory cytokines
  • Enhance fibroblast and macrophage activity

TB-500 (Thymosin Beta-4 fragment)

Preclinical models indicate TB-500 may:

  • Enhance cell migration to sites of injury
  • Support tissue remodeling and recovery
  • Reduce inflammatory responses
  • Improve healing in muscle, cardiac, and soft tissues

GHK-Cu

Cellular studies suggest GHK-Cu may:

  • Increase collagen, elastin, and ECM protein production
  • Promote wound healing and tissue rejuvenation
  • Reduce oxidative stress and inflammation
  • Stimulate gene expression associated with repair and remodeling

Rationale for Combination Research

The synergy in this triple-peptide blend arises from the distinct but complementary biological pathways each peptide influences:

BPC-157 contributes:

  • Enhanced microvascular growth
  • Modulation of inflammatory responses
  • Support of soft-tissue regeneration

TB-500 contributes:

  • Improved cellular migration and cytoskeletal remodeling
  • Tissue repair during early injury phases
  • Anti-inflammatory effects

GHK-Cu contributes:

  • ECM rebuilding (collagen, elastin, glycosaminoglycans)
  • Antioxidant and anti-inflammatory activity
  • Support for dermal and connective tissue regeneration

Together, research suggests the blend may:

  • Accelerate and strengthen tissue healing
  • Improve extracellular matrix quality and structural integrity
  • Reduce inflammation while promoting balanced remodeling
  • Offer a broader multi-layered regenerative response than any single peptide alone

Areas of Emerging Scientific Interest

Preclinical research continues to explore this peptide combination in:

  • Soft-tissue injury and orthopedic recovery models
  • Tendon, ligament, and muscle repair studies
  • Dermal and connective-tissue regeneration
  • Chronic inflammation models
  • Angiogenesis and microvascular recovery
  • Wound healing and post-surgical recovery

The blend is frequently used in studies seeking comprehensive repair across multiple tissue layers.

Additional Information

mg/vial

10mg/10mg/50mg/10mg*1vial

COA / HPLC / MS

Reviews

There are no reviews yet.

Be the first to review “KLOW (BPC-157 / TB500 / GHK-Cu / KPV)”

Your email address will not be published. Required fields are marked *

Related Products